A team of scientists from France has recently demonstrated the efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma therapy in improving the survival rate among patients with B-cell ...

The WHO's Guideline Development group found that "there was no clear benefit for critical outcomes such as mortality and mechanical ventilation." Convalescent plasma therapy gives Covid patients a ...

Plasma treatment encompasses a suite of techniques in which ionised gases—often generated at or near ambient temperature—interact with surfaces, liquids or gases to effect chemical, physical and ...

Findings from a nationwide, multicenter study led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health suggest that patients with COVID-19 have less chance of developing ...

Plasma, the fourth state of matter, is created by applying electrical energy to a gas, causing ion formation. When an energy source, such as electrical energy or radio waves, transfers energy to gas ...

The FDA’s withdrawal of its authorization for Evusheld, a monoclonal antibody therapy used to prevent and treat Covid-19, leaves no monoclonals available for this purpose. Another monoclonal, ...

Convalescent plasma therapy has shown a weak benefit in patients with severe or life-threatening Covid-19. However, when considering safety, 1 some have advocated its use beyond this limited scope.

Early in the pandemic, scientists thought “convalescent plasma” might be a way to treat COVID-19. By giving patients the plasma of people who had recovered (or convalesced) from COVID-19, the idea was ...

Plasma donation is a specific form of blood donation whereby plasma, the clear liquid component of whole blood, is collected during donation through a process known as plasmapheresis. During ...

ADMA Biologics ADMA and Takeda TAK are leading players in the plasma derived immunoglobulin sector. ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of ...